Bacillus Calmette-Guérin Revaccination Questionable with Low Tuberculosis Incidence
- 1 April 1998
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 157 (4) , 1324-1327
- https://doi.org/10.1164/ajrccm.157.4.9706037
Abstract
Bacillus Calmette-Guerin (BCG) revaccination was discontinued in Finland in 1990. The objective of this study was to assess the impact of BCG revaccination of tuberculin-negative school-children in prevention of tuberculosis. The tuberculosis cases in 1990-1995 were calculated among age cohorts born 1979-1984 and no longer covered by the BCG revaccination program. Corresponding data were collected for comparison from the period of revaccination in 1980-1985 among age cohorts born in 1969-1974. The National Tuberculosis Register was reviewed in order to observe the tuberculosis trend since 1980 in the age groups of 10-14 and 15-19 yr. Three cases of tuberculosis have been registered among non-BCG-revaccinated children during 6 yr after discontinuation of the program, i.e., 2.23 cases (95% CI 0.72 to 6.90) per million person yr. The control group revealed five cases, 3.78 (95% CI 1.57 to 9.07) per million person yr. The relative risk of tuberculosis in non-BCG-revaccinated children is 0.59 (95% CI 0.14 to 2.47) compared with the control group. The incidence of tuberculosis has continued to decline among adolescents since 1980. The follow-up data confirm that the cessation of BCG revaccination program had no effect on the continuing overall decline of tuberculosis in Finland. The efficacy of BCG revaccination seems to be low or nonexistent in countries with low tuberculosis incidence.Keywords
This publication has 14 references indexed in Scilit:
- Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction?American Journal of Respiratory and Critical Care Medicine, 1995
- Pros and Cons of BCG Vaccination in Countries with Low Incidence of TuberculosisInfection Control & Hospital Epidemiology, 1994
- A re-examination of the variations in the efficacy of BCG vaccination against tuberculosis in clinical trialsTubercle and Lung Disease, 1994
- Six years' experience with the discontinuation of BCG vaccinationTubercle and Lung Disease, 1993
- Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago, ChileTubercle and Lung Disease, 1992
- Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A reviewTubercle and Lung Disease, 1992
- The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989Tubercle and Lung Disease, 1992
- The BCG Story: Lessons from the Past and Implications for the FutureClinical Infectious Diseases, 1989
- The effects of the scheme for BCG vaccination of schoolchildren in England and Wales and the consequences of discontinuing the scheme at various dates.Journal of Epidemiology and Community Health, 1989
- Childhood tuberculosis in SwedenTubercle, 1983